×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4018631
Return to Previous Page
4018631

Availability: In stock

IGF-I Analog
H-Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys-OH (Disulfide bond)

4018631

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4018631.0001 1 mg Ships within 3-5 business days  
CHF 273.00
CHF 253.89 (7%)

Details

The IGF-I peptide analog JB-1 was able to inhibit the autophosphorylation of the IGF-I receptor by IGF-I as well as the growth of several different cell types, including prostate carcinoma cells and SV40-transformed cells. IGF1 analogs as JB-1 might be useful in treating abnormal cell growth.
Catalog Number H-1356
One Letter Code CYAAPLKPAKSC
Synonyms JB1
Molecular Formula C₅₅H₈₈N₁₄O₁₅S₂
Relative Molecular Mass 1249.52
CAS Registry Number 147819-32-7
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Cancer Research
Diabetes
Growth Factors
Links / Documents:
Brochures:

Bachem product citations

M.Shigyo et al., Sci. Rep., 5, 12055 (2015)
E.Martin-Montanez et al., Biochim. Biophys. Acta, 1842, 1041 (2014)
G.M.Escott et al., Biochim. Biophys. Acta, 1838, 1332 (2014)
S.J.Park et al., Endocrinol. Metab. (Seoul), 29, 336 (2014)
S.Baldini et al., J. Neurosci., 33, 11715 (2013)
Q.G.Gao et al., Eur. J. Pharmacol., 677, 39 (2012)
R.C.Agis-Balboa et al., EMBO J., 30, 4071 (2011)
B.A.Hoshaw et al., Eur. J. Pharmacol., 594, 109 (2008)
J.Bonnefont et al., Mol. Pharmacol., 71, 407 (2007)
W.A.Kues et al., Biol. Reprod., 72, 1020 (2005)
S.Sperandio et al, Cell. Death Differ., 11, 1066 (2004)
A.M.Etgen and M.Acosta-Martinez, Endocrinology, 144, 3828 (2003)
J.Ren et al., Cardiovasc. Res., 57, 738 (2003)
H.M.Brown-Borg et al., Exp. Biol. Med. (Maywood), 227, 94 (2002)
J.F.Kuemmerle and H.Zhou, J. Biol. Chem., 277, 20563 (2002)
K.K.Hintz and J.Ren, Diabetes Res. Clin. Pract., 55, 89 (2002)
K.K.Hintz and J.Ren, Diabetes Res. Clin. Pract., 55, 89 (2002)
R.Fukuda et al., J. Biol. Chem., 277, 38205 (2002)
J.Ren, Cardiovasc. Res., 46, 162 (2000)
M.van Eickels et al., Br. J. Pharmacol., 131, 1592 (2000)

Product citations

L.Croci et al., Cell Death Differ., 18, 48 (2011)
G.Camarero et al., Dev. Biol., 262, 242 (2003)
Z.Pietrzkowski et al., Cancer Res., 53, 1102 (1993)
Z.Pietrzkowski et al., Cancer Res., 52, 6447 (1992)